📰 Melissab Epperly News
Melissab Epperly News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Melissab Epperly. Real-time updates on events, politics, business and more.
May 1, 2024
Abrdn plc purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 40,156 shares of the company’s stock, valued at approximately $608,000. abrdn plc owned about 0.06% of Zentalis Pharmaceuticals as […]
April 24, 2024
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) fell 7.1% during mid-day trading on Wednesday . The company traded as low as $11.63 and last traded at $11.68. 445,154 shares were traded during mid-day trading, a decline of 44% from the average session volume of 791,847 shares. The stock had previously closed at […]
April 23, 2024
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […]
April 23, 2024
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year […]
April 11, 2024
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was up 6.3% during mid-day trading on Tuesday . The company traded as high as $15.66 and last traded at $15.54. Approximately 105,881 shares changed hands during trading, a decline of 87% from the average daily volume of 796,470 shares. The stock had previously closed […]
March 12, 2024
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded up 7.7% on Tuesday . The stock traded as high as $15.03 and last traded at $15.01. 176,839 shares traded hands during trading, a decline of 78% from the average session volume of 812,871 shares. The stock had previously closed at $13.94. Wall Street Analysts Forecast […]
March 9, 2024
Kennedy Capital Management LLC boosted its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 156,475 shares of the company’s stock after purchasing an additional 4,178 shares during the […]
March 1, 2024
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Analysts at Leerink Partnrs issued their FY2027 earnings per share estimates for shares of Zentalis Pharmaceuticals in a report released on Tuesday, February 27th. Leerink Partnrs analyst A. Berens anticipates that the company will earn ($2.59) per share for the year. Leerink Partnrs currently has a “Market […]
February 23, 2024
Federated Hermes Inc. lessened its stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% in the third quarter, HoldingsChannel.com reports. The firm owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated Hermes Inc.’s holdings in Zentalis Pharmaceuticals were worth $39,071,000 at the end of the […]
February 23, 2024
Federated Hermes Inc. cut its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated […]